OncoCalendar

The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing on using precision medicine to manage patients with HR-positive, HER2-negative metastatic breast cancer. The event is scheduled to take place on March 4–5, 2026, in […]

The Lung Health Foundation is offering a free, accredited virtual "Lunch and Learn" series - the Provider Education Series - consisting of three one-hour sessions designed to deliver high-impact, evidence-based education to healthcare professionals. These sessions will provide practical insights from expert speakers on the diagnosis, treatment, and management of lung diseases, with a focus […]

The APPOS Charlotte 2026: Advanced Practice Providers Oncology Summit returns to Charlotte on March 6–7, 2026, bringing oncology clinicians together for a focused, two-day CE program dedicated to the latest advances in cancer care. Designed with and for advanced practice providers, this summit delivers evidence-based updates, practical management strategies, and collaborative learning to strengthen patient care […]

The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research. Scheduled for March 6–7, 2026, in Zurich, Switzerland, the course focuses on multidisciplinary care, […]

Pathology Update 2026 is the annual scientific conference hosted by The Royal College of Pathologists of Australia (RCPA). It will take place from March 6 to March 8, 2026, in Sydney, NSW. The meeting provides a multi-disciplinary pathology program for pathologists, scientists, and trainees, focusing on new developments and challenges in the field under the […]

The 26th Multidisciplinary Management of Cancers: A Case-Based Approach, held March 6–8, 2026, at the Meritage Resort and Spa, will focus on the latest multidisciplinary strategies in clinical oncology. The meeting features tumor board–style case discussions across breast, gastrointestinal, genitourinary, hematologic, lymphoma, and thoracic cancers, led by faculty and expert panels from Stanford, UC Davis, […]

The OPN Pacific Northwest Chapter Conference 2026 is a one-day regional summit organized by the Oncology Pharmacy Network, scheduled for March 7, 2026. The conference will be held at the Crowne Plaza in Portland, Oregon, United States. Designed for hematology/oncology pharmacy clinicians, including pharmacists and technicians, the event provides a platform to network, collaborate, and […]

The ELRIG Cell and Gene Therapy 2026 is a free-to-attend, two-day scientific conference scheduled for March 9–10, 2026, in Cambridge, UK. Organized by the European Laboratory Research and Innovation Group (ELRIG), this event focuses on the translational journey of advanced therapies from preclinical innovation to clinical application. The technical program features four key tracks: gene […]

The 2026 NCODA Global Oncology and Hematology Congress is a premier international gathering of oncology, hematology, and technology experts scheduled for March 11–12, 2026, in Dublin, Ireland. Organized by NCODA, the congress focuses on "bridging innovation and patient-centered care" through collaborative sessions that highlight best practices in medically integrated oncology. The technical program is designed […]

The ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom. The application deadline is January 21, 2026, at 23:59 CET, and the course is accredited for 16 ESMO-MORA category 1 points. The learning objectives cover the full spectrum of thoracic oncology, from screening […]

"The Role of Liquid Biopsy in the Characterization of Predictive Markers of Response in Patients with Lung Cancer" is a specialized medical conference scheduled for March 12, 2026, in Bari, Italy. This educational event is designed specifically for healthcare professionals - including Pathologists, Oncologists, Biologists, and Laboratory Technicians - to explore advanced diagnostic techniques that […]

The 12th ImmunoTherapy of Cancer Conference (ITOC12) is a European meeting scheduled to take place from March 12 – 14, 2026, in Munich, Germany. The conference provides a global platform focused on translational research in immuno-oncology, serving as a forum for the discussion of early clinical translation and its unique challenges. Organized by WMA GmbH […]